ABOUT US
FOR ENTREPRENEURS, BY ENTREPRENEURS
Starting and evolving a new venture from the initial vision, through the start-up phase to becoming a profitable, sustainable organization requires passionate entrepreneurship, perseverance and ideally instant access – to entrepreneurial partnership and support in combination with established trust, technology and market networks and, of course, finance.
evo-partners is a single family office rooted in a global network of experienced, successful serial entrepreneurs and an array of established and exponentially growing portfolio companies in the life-sciences, nuclear technologies and digital ecosystems. We provide instant access to tried and tested entrepreneurial experience, skilled specialists, leading academic institutions and finance to our portfolio companies.
The heart and start of all our projects lies in identifying and building the combination of a transformational solution to a well defined problem with a visionary and passionate team – above all and always focused on a massively transformational purpose.
OUR APPROACH
PERSISTENT ENTREPRENEURIAL AND CORPORATE EVOLUTION
Fundamental purpose in combination with a solid vision triggers deep entrepreneurial passion. This in turn transfers to perseverance and a spirited corporate culture in new ventures.
This energy is in our experience the fundamental fuel, which combined with ability and access are the key prerequisites for any evolving venture. It is crucial to overcome the multitude of challenges, crises and hurdles on the journey from vision to success.
Good, long-term strategic planning is the backbone and underlying foundation for any purpose driven corporate evolution process. This is especially important in the life-sciences, where a visionary technological solution must always come together with clinical proof and the management of regulatory frameworks.
Well defined development objectives and phases, key waypoints and strategic foresight enable any technology driven venture to measure success and generate optionality along the way. It therefore also sets a clear framework for its financing strategy.
And equally importantly: Planning for exponential growth requires early access to real world market intelligence, experience, supplemental technologies and fitting, savvy investors. This accessibility will enable the development of indispensable intelligent long-term roadmaps.
Rooted in the histories of our founding partner and the trust relationships and track-record built throughout numerous activities and projects over the past two decades, evo-partners has itself become a node with both centrality and connectivity in its eco-systems global network of people, companies, partners, academia, and institutions.
We attempt to maximize communication, exchange of ideas and mutual support, synergy and collaboration between our portfolio companies and new ventures, wherever feasible and reasonable.
Access to global markets, real world implementation experience in a variety of key global regions (such as China and India in combination with the EU and North America) and the resulting access to up-to-date market intelligence has furthermore become a core contribution to the strategic business development activities and exponential growth trajectories of our network of portfolio companies.
Purpose, Vision & Passion
Fundamental purpose in combination with a solid vision triggers deep entrepreneurial passion. This in turn transfers to perseverance and a spirited corporate culture in new ventures.
This energy is in our experience the fundamental fuel, which combined with ability and access are the key prerequisites for any evolving venture. It is crucial to overcoming the multitude of challenges, crises and hurdles on the journey from vision to success.
Long Term Strategy & Roadmaps
Good, long-term strategic planning is the backbone and underlying foundation for any purpose driven corporate evolution process. This is especially important in the life-sciences, where a visionary technological solution must always come together with clinical proof and the management of regulatory frameworks.
Well defined development objectives and phases, key waypoints and strategic foresight enable any technology driven venture to measure success and generate optionality along the way. It therefore also sets a clear framework for its financing strategy.
And equally importantly: Planning for exponential growth requires early access to real world market intelligence, experience, supplemental technologies and fitting, savvy investors. This accessibility will enable the development of indispensable intelligent long-term roadmaps.
Global Networks & Market Access
Rooted in the histories of our founding partner and the trust relationships and track-record built throughout numerous activities and projects over the past two decades, evo-partners has itself become a node with both centrality and connectivity in its eco-systems global network of people, companies, partners, academia, and institutions.
We attempt to maximize communication, exchange of ideas and mutual support, synergy and collaboration between our portfolio companies and new ventures, wherever feasible and reasonable.
Access to global markets, real world implementation experience in a variety of key global regions (such as China and India in combination with the EU and North America) and the resulting access to up-to-date market intelligence has furthermore become a core contribution to the strategic business development activities and exponential growth trajectories of our network of portfolio companies.
Our P3F Framework
How we evaluate potential investments.
P3F = People, Product, Plan, Finance
People
Vision
Seeing the solution to a massive medical/human problem
Passion
Finding fundamental purpose in solving the problem
Will
The strength to stay focused and on target no matter what
Ability
Learning, learning, learning as the team moves forward
Perseverance
Relentlessly overcoming obstacles and setbacks
Product
Problem + Solution
Clearly defined problem and solution frameworks
Creativity
Innovative and inspired solutions
Technology
Professional understanding of technologies and regulatory frameworks
Optionality
Alternative development pathways and technological
plan B's
Competitivity
Strategic positioning and headstart
Platform Potential
Applicability as platform solutions
Plan
Major Milestones
From the feasibility to proof-of concept to approved product
Phased Roadmap
Definition of distinct phases for de-risking and go-to-market
Momentum
Inherent increase of momentum towards milestones and value inflections
Frequency
Enabling frequent reviews of decision-making milestones enabling necessary course corrections
Feedback Loops
To assure optimized convergence of technical, financial and market intelligence
Finance
Phased Financing
In conjunction with the defined road map and milestones
Phased Financing Roadmap
Plan and organize for financing ongoing phase plus subsequent phase subsequent injections subject to clear and transparent objectives on the phased roadmap
No Artificial Timelines
Which are detrimental to responsible clinical and regulatory development
Value Inflection Strategy
Planning, tracking and implementation of value inflections in accordance with phased roadmap
Purpose-Driven Positive Impact.
Venture by venture.
LIFE SCIENCES
RADIOPHARMACEUTICALS | PRECISION MEDICINE | BIOMEDICAL ENGINEERING
ITM (Isotopen Technologien München) – A leading radiopharmaceutical group focused on the production, development, and global supply of medical radioisotopes and targeted radionuclide therapies.
.png){kind=logo}
Telix is a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals.
ICPO Foundation – An international non-profit organization dedicated to advancing access, education, and standardization in radiomolecular precision oncology and theranostics worldwide.
OncoBeta has developed the world-first epidermal radioisotope therapy for the effective treatment of non-melanoma skin cancers, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).
Navigo Proteins develops custom affinity ligands for biopharmaceutical purification and Affilin®-based therapeutics for targeted drug delivery.
Optigo Biotherapeutics – A preclinical ophthalmology biotech developing long-acting, bi-functional intravitreal biologics that anchor to ocular proteins to reduce injection frequency for retinal diseases.
MTIC (Melbourne Theranostic Innovation Centre) – A clinical research and imaging center specializing in PET/CT and theranostic innovation for cancer diagnosis and treatment in Australia.
GAIASO Theranostics – A biotech company developing precision-targeted radioligand therapies for female cancers, leveraging deep insights into female biology and theranostic platforms to offer new options in diagnosis and treatment.
Munich Precision Oncology GmbH (MPO) is a German company building dedicated theranostics centres to provide patient-centred, state-of-the-art radiomolecular precision oncology services, starting with a pilot facility in the Munich area.
NUCLEAR TECHNOLOGIES
FISSION | FUSION | TRANSMUTATION
Astral Systems - A UK-based deep-tech company developing compact “Multi-State Fusion” reactors to enable on-site production of medical isotopes and advanced neutron flux services, thus addressing critical supply-chain gaps in radiopharmaceuticals and enabling next-generation nuclear applications.
DIGITAL ECOSYSTEMS & AI
WEB3 | WEB4 | BLOCKCHAIN
Brava simplifies stablecoin management with tools for yield optimization, risk assessment, and integrated cover access, empowering users to get competitive yield options while maintaining full custody of their assets.
Silencio – A platform leveraging AI and blockchain-based data-aggregation to create a crowdsourced database of global noise pollution and environmental sound exposure.
Vara – A health-tech company using AI to support radiologists in breast cancer screening through automated mammography analysis and workflow optimization.
Authentic Vision – A technology company specializing in anti-counterfeiting and product authentication solutions using unique holographic tags paired with mobile verification.
KITRO – A food-waste analytics startup that uses AI-powered image recognition and smart hardware to measure, analyze, and reduce food waste in commercial kitchens.